» Articles » PMID: 36443780

A Qualitative Exploration of People Living with Idiopathic Pulmonary Fibrosis Experience of a Virtual Pulmonary Rehabilitation Programme

Overview
Journal BMC Pulm Med
Publisher Biomed Central
Specialty Pulmonary Medicine
Date 2022 Nov 29
PMID 36443780
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pulmonary rehabilitation (PR) is recommended in the treatment of people with idiopathic pulmonary fibrosis (IPF). Little is known about the experiences of people with IPF of PR. Due to Covid-19 there has been a rapid shift of PR services to remote/virtual delivery.

Objective: To explore people living with IPFs experience of a virtual PR (VPR) programme.

Methods: All patients with a diagnosis of IPF in a stable phase of the disease were invited to participate in virtual PR: a 10 week exercise programme delivered twice-weekly for one hour. One-to-one semi- structured interviews were conducted within one week following the programme. All interviews were recorded, transcribed and analysed using Braun and Clarke thematic analysis by two independent assessors.

Results: N=13 participants took part in the semi-structured interviews, mean (standard deviation (SD)) age 69.5(10.4) years; 7M:6F. Mean (SD) FEV 2.6(0.3)L, FVC 2.9(0.4)L. Four key themes were identified: 1) The impact of VPR on health and outlook, (2) The reality of VPR, (3) Being active after VPR and (4) Living with IPF during the COVID-19 Pandemic. Participants reported high levels of enjoyment and engagement with the programme regardless of the health benefits experienced. Most participants expressed a desire for a longer programme. Participants expressed different levels of maintenance with exercise since finishing the programme, specific motivators and strategies for maintenance included lung transplant, the maintenance of benefits from the programme and social support. COVID-19 and the restrictions imposed had some negative impacts on some participants lives, engaging with PR helped overcome some of these.

Conclusion: Despite the progressive nature of IPF, all participants expressed high levels of enjoyment with the programme. Future research should explore strategies for maintenance post PR and the optimum duration of PR for people with IPF.

Citing Articles

Precision Oncology, Artificial Intelligence, and Novel Therapeutic Advancements in the Diagnosis, Prevention, and Treatment of Cancer: Highlights from the 59th Irish Association for Cancer Research (IACR) Annual Conference.

Lynch S, Heeran A, Burke C, Lynam-Lennon N, Eustace A, Dean K Cancers (Basel). 2024; 16(11).

PMID: 38893110 PMC: 11171401. DOI: 10.3390/cancers16111989.


Changes in physical activity in people with idiopathic pulmonary fibrosis before and after virtual pulmonary rehabilitation: a feasibility study.

OShea O, Murphy G, Fox L, OReilly K BMC Pulm Med. 2024; 24(1):215.

PMID: 38698361 PMC: 11064383. DOI: 10.1186/s12890-024-03030-9.


Using Remote Technology to Engage Patients with Interstitial Lung Diseases in a Home Exercise Program: A Pilot Study.

Sarmento A, King K, Sanchez-Ramirez D Life (Basel). 2024; 14(2).

PMID: 38398774 PMC: 10890249. DOI: 10.3390/life14020265.


Remote pulmonary rehabilitation for interstitial lung disease: developing the model using experience-based codesign.

Brighton L, Spain N, Gonzalez-Nieto J, Ingram K, Harvey J, Man W BMJ Open Respir Res. 2024; 11(1).

PMID: 38378779 PMC: 10882322. DOI: 10.1136/bmjresp-2023-002061.

References
1.
Martinu T, Babyak M, OConnell C, Carney R, Trulock E, Davis R . Baseline 6-min walk distance predicts survival in lung transplant candidates. Am J Transplant. 2008; 8(7):1498-505. PMC: 2714545. DOI: 10.1111/j.1600-6143.2008.02264.x. View

2.
de Vries J, Kessels B, Drent M . Quality of life of idiopathic pulmonary fibrosis patients. Eur Respir J. 2001; 17(5):954-61. DOI: 10.1183/09031936.01.17509540. View

3.
Riddell P, Kleinerova J, Eaton D, Healy D, Javadpour H, McCarthy J . Meaningful survival benefit for single lung transplantation in idiopathic pulmonary fibrosis patients over 65 years of age. Eur Respir J. 2020; 56(1). DOI: 10.1183/13993003.02413-2019. View

4.
Amor M, Rosengarten D, Shitenberg D, Pertzov B, Shostak Y, Kramer M . Lung Transplantation in Idiopathic Pulmonary Fibrosis: Risk Factors and Outcome. Isr Med Assoc J. 2020; 22(12):741-746. View

5.
Castleberry A, Englum B, Snyder L, Worni M, Osho A, Gulack B . The utility of preoperative six-minute-walk distance in lung transplantation. Am J Respir Crit Care Med. 2015; 192(7):843-52. PMC: 5447300. DOI: 10.1164/rccm.201409-1698OC. View